| Nome |
# |
|
Meaning of elevated CA 19-9 serum levels in chronic hepatitis and HCV-related cirrhosis, file dfe4d228-60d5-bb0a-e053-d805fe0a78d9
|
737
|
|
Combination theraphy ezetimibe/simvastatin decreases the supersaturation in gallbladder bile and prevents cholesterol gallstones formation, file dfe4d227-43c2-bb0a-e053-d805fe0a78d9
|
419
|
|
Endozepine-4 levels are increased in hepatic coma., file dfe4d228-54f9-bb0a-e053-d805fe0a78d9
|
71
|
|
D-dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosis, file dfe4d229-7d9d-bb0a-e053-d805fe0a78d9
|
62
|
|
Rare benign tumors of the liver: still rare?, file dfe4d228-5d53-bb0a-e053-d805fe0a78d9
|
57
|
|
Critical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electronic cigarettes, file dfe4d22e-a7c2-bb0a-e053-d805fe0a78d9
|
37
|
|
Type II Mixed Cryoglobulinemia In Patients With Hepatitis C Virus: Treatment with Pegylated-Interferon and Ribavirin, file dfe4d227-1f03-bb0a-e053-d805fe0a78d9
|
35
|
|
Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer, file dfe4d228-ba94-bb0a-e053-d805fe0a78d9
|
32
|
|
Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research, file dfe4d22e-c44f-bb0a-e053-d805fe0a78d9
|
26
|
|
Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational study, file dfe4d227-abfd-bb0a-e053-d805fe0a78d9
|
25
|
|
Silybin supplementation during HCV therapy with pegylated interferon-a plus ribavirin reduces depression and anxiety and increases work ability, file dfe4d229-389d-bb0a-e053-d805fe0a78d9
|
23
|
|
Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance, file dfe4d228-385c-bb0a-e053-d805fe0a78d9
|
22
|
|
Silybin-vitamin E-phospholipids complex reduces liver fibrosis in patients with chronic epatiti C treated with pegylated interferon α and ribavirin, file dfe4d227-306c-bb0a-e053-d805fe0a78d9
|
21
|
|
Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research (Internal and Emergency Medicine, (2022), 17, 3, (887-909), 10.1007/s11739-022-02967-1), file 0240b722-5898-4ca4-b5e4-4dfb5780ba7d
|
18
|
|
Anorectal mucosal melanoma, file dfe4d228-c793-bb0a-e053-d805fe0a78d9
|
18
|
|
The HCV Sicily Network: a web-based model for the management of HCV chronic liver diseases, file dfe4d227-4788-bb0a-e053-d805fe0a78d9
|
16
|
|
Gut Microbiota in Inflammatory Bowel Diseases: A Possible Role in the Development of Rapidly Evolving Chronic Hepatitis and Endothelial Dysfunction with Increased Cardiovascular Risk, file dfe4d228-8b67-bb0a-e053-d805fe0a78d9
|
15
|
|
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study, file dfe4d228-41e6-bb0a-e053-d805fe0a78d9
|
14
|
|
Giant cavernous liver hemangiomas: is it the time to change the size categories?, file dfe4d228-6090-bb0a-e053-d805fe0a78d9
|
14
|
|
High carbohydrate 19-9 antigen serum levels in patients with nonmelanoma skin cancer and primary occult cancer, file dfe4d22e-7e94-bb0a-e053-d805fe0a78d9
|
14
|
|
An unusual case of HBV reactivation in a patient with cholangitis and choledocho-lithiasis undergone to ERCP. A case report, file dfe4d22d-71db-bb0a-e053-d805fe0a78d9
|
13
|
|
Aberrant sialylation in a patient with a HNF1α variant and liver adenomatosis, file dfe4d22e-86fc-bb0a-e053-d805fe0a78d9
|
13
|
|
Carotid Intima-Media Thickness and Liver Histology in Hemodialysis Patients with Non-Alcoholic Fatty Liver Disease, file dfe4d228-5a78-bb0a-e053-d805fe0a78d9
|
12
|
|
A lethal complication after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma., file dfe4d228-5b11-bb0a-e053-d805fe0a78d9
|
12
|
|
Hepatocellular Carcinoma: present and future, file dfe4d228-5b26-bb0a-e053-d805fe0a78d9
|
12
|
|
Evaluation of health status in patients with hepatitis c treated with and without interferon, file dfe4d228-97d6-bb0a-e053-d805fe0a78d9
|
12
|
|
Hepatocellular carcinoma markers in the omics era: the glycomic analysis, file b7088014-5806-422c-904b-7029a7486a12
|
11
|
|
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions, file dfe4d228-fcb7-bb0a-e053-d805fe0a78d9
|
11
|
|
Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature, file dfe4d229-3235-bb0a-e053-d805fe0a78d9
|
11
|
|
Carnitine Serum Levels in Frail Older Subjects, file dfe4d22d-86c7-bb0a-e053-d805fe0a78d9
|
11
|
|
Liver and Cardiovascular Mortality After Hepatitis C Virus Eradication by DAA: data from RESIST‐HCV Cohort, file dfe4d22e-821e-bb0a-e053-d805fe0a78d9
|
11
|
|
Respiratory and Cardiovascular Health Effects of e-Cigarette Substitution: Protocol for Two Living Systematic Reviews, file dfe4d22e-915a-bb0a-e053-d805fe0a78d9
|
11
|
|
Chronic hepatitis C: This and the new era of treatment, file dfe4d227-2d0a-bb0a-e053-d805fe0a78d9
|
10
|
|
Current practice of chronic hepatitis B treatment in Southern Italy, file dfe4d228-5a5f-bb0a-e053-d805fe0a78d9
|
10
|
|
Laparoscopic Reversal of Hartmann's Procedure: State of the Art 20 Years after the First Reported Case, file dfe4d228-5d50-bb0a-e053-d805fe0a78d9
|
10
|
|
Commentary on "Insertion of Totally Implantable Central Venous Access Devices by Surgeons" - What Is the Role of Surgeons When Implanting a Totally Implantable Venous Access Device to Prevent Immediate Complications?, file dfe4d228-6202-bb0a-e053-d805fe0a78d9
|
10
|
|
Folate levels in hepatocellular carcinoma patients with portal vein thrombosis, file dfe4d22d-72a4-bb0a-e053-d805fe0a78d9
|
10
|
|
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid, file 47c4f675-226c-4d6f-8fe4-0c266c42ca61
|
9
|
|
Gut microbiota in alcoholic liver disease: Pathogenetic role and therapeutic perspectives, file dfe4d228-553b-bb0a-e053-d805fe0a78d9
|
9
|
|
Totally Implantable Venous Access Devices: Efforts Are Needed to Standardize Procedures to Avoid Complications, file dfe4d228-5aac-bb0a-e053-d805fe0a78d9
|
9
|
|
Carbohydrate 19.9 Antigen Serum Levels in Liver Disease, file dfe4d228-5b13-bb0a-e053-d805fe0a78d9
|
9
|
|
Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial., file dfe4d228-5d54-bb0a-e053-d805fe0a78d9
|
9
|
|
Does follow-up offer the best quality of life for patients affected by so-called 'giant' haemangiomas of the liver?, file dfe4d228-5dbe-bb0a-e053-d805fe0a78d9
|
9
|
|
Greater severity of new onset asthma in allergic subjects who smoke: a 10-year longitudinal study, file dfe4d228-604d-bb0a-e053-d805fe0a78d9
|
9
|
|
Resveratrol in Patients with Minimal Hepatic Encephalopathy, file dfe4d228-de3b-bb0a-e053-d805fe0a78d9
|
9
|
|
Real-world experience with obeticholic acid in patients with primary biliary cholangitis, file dfe4d22e-6366-bb0a-e053-d805fe0a78d9
|
9
|
|
Focal Nodular Hyperplasia From The Surgery To The Follow-Up. Change Of Therapeutic Approach, file 184287d9-4107-43c9-81e6-6b7faa66d259
|
8
|
|
Incidence and causes of neonatal hyperbilirubinemia in a center of Catania, file dfe4d228-5adb-bb0a-e053-d805fe0a78d9
|
8
|
|
Serum markers of intrahepatic cholangiocarcinoma, file dfe4d228-5c77-bb0a-e053-d805fe0a78d9
|
8
|
|
Hepatitis C Virus Infection in Children and Pregnant Women: An Updated Review of the Literature on Screening and Treatments, file dfe4d22b-13b3-bb0a-e053-d805fe0a78d9
|
8
|
|
Genotype-phenotype variable correlation in Wilson disease: clinical history of two sisters with the similar genotype, file dfe4d22c-8e80-bb0a-e053-d805fe0a78d9
|
8
|
|
Serum Folate deficiency in HCV related Hepatocellular Carcinoma, file dfe4d22e-e41d-bb0a-e053-d805fe0a78d9
|
8
|
|
Intraoperative Identification of Biliocystic Communication Could be the Key to Avoiding Postoperative Complications Independent of the Adopted Surgical Technique to Treat Hydatid Cysts, file dfe4d228-5b0f-bb0a-e053-d805fe0a78d9
|
7
|
|
What is changing in indications and treatment of hepatic hemangiomas. A review, file dfe4d228-5dd2-bb0a-e053-d805fe0a78d9
|
7
|
|
Potential role of probiotics on colorectal cancer prevention, file dfe4d228-5f69-bb0a-e053-d805fe0a78d9
|
7
|
|
Hepatocellular carcinoma serum markers, file dfe4d227-0d9b-bb0a-e053-d805fe0a78d9
|
6
|
|
Elevated serum levels of Chromogranin A in hepatocellular carcinoma, file dfe4d228-5acf-bb0a-e053-d805fe0a78d9
|
6
|
|
Effect of pre- and post-treatment α-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study, file dfe4d228-5dcb-bb0a-e053-d805fe0a78d9
|
6
|
|
Improvement of health-related quality of life and psychological well-being after HCV eradication with direct-acting antiviral agents. Real life setting data of an Italian cohort valued by Hepatitis Quality of Life Questionnaire (HQLQv2), file dfe4d22e-3f0d-bb0a-e053-d805fe0a78d9
|
6
|
|
Management of Hepatocellular Carcinoma: an update at the Start of 2014, file dfe4d227-02b0-bb0a-e053-d805fe0a78d9
|
5
|
|
Systemic Therapies in Hepatocellular carcinoma: present and future, file dfe4d228-58cc-bb0a-e053-d805fe0a78d9
|
5
|
|
L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin, file dfe4d228-5a67-bb0a-e053-d805fe0a78d9
|
5
|
|
Sustained virological response in patients with HCV treated with daclatasvir plus sofosbuvir, with or without ribavirin: a large, field-practice study, file dfe4d22e-1956-bb0a-e053-d805fe0a78d9
|
5
|
|
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma, file 27593752-036b-49ed-8945-624866909dd9
|
4
|
|
Emerging hepatic syndromes: pathophysiology, diagnosis and treatment, file dfe4d228-57ae-bb0a-e053-d805fe0a78d9
|
4
|
|
Individualized Treatment of Genotype 1 Naıve Patients: An Italian Multicenter Field Practice Experience, file dfe4d228-5dd0-bb0a-e053-d805fe0a78d9
|
4
|
|
Erythropoitin in liver cirrhosis: Two questions without anwers, file dfe4d228-5fa8-bb0a-e053-d805fe0a78d9
|
4
|
|
Relationship between circulating interleukin-10 and histological features in patients with chronic C hepatitis, file dfe4d228-5ff2-bb0a-e053-d805fe0a78d9
|
4
|
|
Prognostic and diagnostic value of des-gamma-carboxyprothrombin in liver cancer, file dfe4d228-5ff8-bb0a-e053-d805fe0a78d9
|
4
|
|
What are the true advantages of devices for hepatic parenchimal transection in open surgery?, file dfe4d228-60e1-bb0a-e053-d805fe0a78d9
|
4
|
|
Hepatitis C virus eradication by direct antiviral agents improves glucose tolerance and reduces post-load insulin resistance in nondiabetic patients with genotype 1., file dfe4d228-fd70-bb0a-e053-d805fe0a78d9
|
4
|
|
Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients., file dfe4d229-b007-bb0a-e053-d805fe0a78d9
|
4
|
|
Digestive diseases. 2022-2025 edition, file 1dd9ce9f-c85d-414c-8970-b48409ef6d29
|
3
|
|
Reduction of volumetric bone mineral density in postmenopausal women with HCV-correlated chronic liver disease: a peripheral quantitative computed tomogtraphy (pQCT) study, file 71430135-88eb-4cc6-ab79-6a27634f87ce
|
3
|
|
In chronic viral hepatitis without malignancy, abnormal serum carbohydrate 19-9 antigen levels are associated with liver disease severity and are related to different viral aetiology 2010 Jun;42(6):458-9, file dfe4d228-5ad9-bb0a-e053-d805fe0a78d9
|
3
|
|
Circulating endothelial-coagulative activation markers after smoking cessation: a 12-month observational study, file dfe4d228-5ff4-bb0a-e053-d805fe0a78d9
|
3
|
|
Epoetin alpha improves the response to antiviral treatment in HCV-related chronic hepatitis, file dfe4d228-5ffc-bb0a-e053-d805fe0a78d9
|
3
|
|
Acetyl-L-carnitine can slow the progression from prefrailty to frailty in older subjects. A randomized interventional clinical trial, file 70ca3a32-d3ce-484c-87f9-38d1e3dc5007
|
2
|
|
A study about mechanism of des-gamma-carboxy prothrombin’s production in hepatocellular carcinoma, file dfe4d226-f824-bb0a-e053-d805fe0a78d9
|
2
|
|
Hepatocellular carcinoma and the risk of occupational exposure., file dfe4d227-20e0-bb0a-e053-d805fe0a78d9
|
2
|
|
A case of Overlap Syndrome:Autoimmune idiopatic hepatitis/pulmonary idiopatic hypertension, file dfe4d228-5ae2-bb0a-e053-d805fe0a78d9
|
2
|
|
Assessing degree of hepatic fibrosis in patients with chronic liver disease using gadoxetic acid-enhanced liver MRI: Preliminary results, file dfe4d228-5cb4-bb0a-e053-d805fe0a78d9
|
2
|
|
The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirin., file dfe4d228-5f9e-bb0a-e053-d805fe0a78d9
|
2
|
|
Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase -2 in patients with HCV-related chronic hepatitis. Relationship to histological features, file dfe4d228-600a-bb0a-e053-d805fe0a78d9
|
2
|
|
Localized fluid collection after carrier-bound fibrin sealant application on liver: complication or proof of efficacy? A long-term clinical observational study, file dfe4d228-6052-bb0a-e053-d805fe0a78d9
|
2
|
|
Immune response in addicts with chronic hepatitis C treated with interferon and ribavirine, file dfe4d228-607e-bb0a-e053-d805fe0a78d9
|
2
|
|
Psychiatric symptoms induced by antiviral therapy in chronic hepatitis C: comparison between interferon-alpha-2a and interferon-alpha-2b., file dfe4d228-60df-bb0a-e053-d805fe0a78d9
|
2
|
|
Circulating adhesion molecules in patients with virus-related chronic diseases of the liver, file dfe4d228-61ae-bb0a-e053-d805fe0a78d9
|
2
|
|
Incidence of Hepatocellular Carcinoma in Patients with HCV-associated Cirrhosis Treated with Direct-Acting Antiviral Agents, file dfe4d229-0d73-bb0a-e053-d805fe0a78d9
|
2
|
|
Telbivudine on-treatment HBsAg loss in naïve HBeAg negative chronic hepatitis B: A case report and brief review of the literature, file dfe4d229-3233-bb0a-e053-d805fe0a78d9
|
2
|
|
Blood homocysteine levels are increased in hepatocellular carcinoma patients with portal vein thrombosis. A single centre retrospective cohort study, file dfe4d22a-725d-bb0a-e053-d805fe0a78d9
|
2
|
|
Efficacy and safety of 12-week DAA regimens in HCV genotype 1b patients with compensated cirrhosis: data of RESIST-HCV Cohort, file dfe4d22c-bb0a-bb0a-e053-d805fe0a78d9
|
2
|
|
Hepatocellular Carcinoma, file dfe4d22e-85e9-bb0a-e053-d805fe0a78d9
|
2
|
|
Terlipressin and Albumin in pateints with cirrhosis and type I Hepatorenal Syndrome, file 74f27895-7aa8-401e-9980-00c5d184af85
|
1
|
|
IL28B CC genotype is associated with higher on-treatment-response rates in pts with HCV-3: interim results of the WRITE study, file dfe4d227-49f8-bb0a-e053-d805fe0a78d9
|
1
|
|
Treatment with rifaximin high dose plus lactulose vs rifaximin standard dose plus for acute hepatic encephalopathy in ed, file dfe4d227-625c-bb0a-e053-d805fe0a78d9
|
1
|
|
Liver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infection, file dfe4d227-a616-bb0a-e053-d805fe0a78d9
|
1
|
|
Plasma ICAM-1 and VCAM-1 levels in type 2 diabetic patients with and without microalbuminuria, file dfe4d228-5561-bb0a-e053-d805fe0a78d9
|
1
|
|
Combined duodenal and pancreatic major trauma in high risk patients: can a partial reconstruction be safe?, file dfe4d228-58c5-bb0a-e053-d805fe0a78d9
|
1
|
|
Circulating erytropoietin in microalbuminuric type 2 diabetic patients with normal renal function: a pilot study, file dfe4d228-5ae6-bb0a-e053-d805fe0a78d9
|
1
|
| Totale |
2.150 |